NFKB1 and neoplasm: An accumulating body of evidence suggests that constitutive activation of the IKK-NFκB pathway can contribute to cancer development, progression and resistance to cancer therapy [2], [3], whereas activation of this pathway by IR can also render tumor cells more resistant to radiotherapy [4].